Sei Investments Co. Buys 7,798 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Sei Investments Co. increased its position in The Cooper Companies, Inc. (NASDAQ:COO) by 2.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 293,265 shares of the medical device company’s stock after acquiring an additional 7,798 shares during the quarter. Sei Investments Co. owned about 0.15% of Cooper Companies worth $26,961,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of COO. Raymond James Financial Inc. purchased a new stake in Cooper Companies in the 4th quarter worth approximately $64,826,000. Victory Capital Management Inc. raised its position in shares of Cooper Companies by 14.6% in the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company’s stock worth $415,985,000 after buying an additional 574,899 shares in the last quarter. JPMorgan Chase & Co. raised its position in shares of Cooper Companies by 13.2% in the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after buying an additional 573,908 shares in the last quarter. Wealthfront Advisers LLC boosted its stake in Cooper Companies by 4,594.1% during the fourth quarter. Wealthfront Advisers LLC now owns 569,812 shares of the medical device company’s stock valued at $52,383,000 after buying an additional 557,673 shares during the period. Finally, Alecta Tjanstepension Omsesidigt purchased a new position in Cooper Companies during the fourth quarter worth about $49,550,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Cooper Companies stock opened at $83.70 on Wednesday. The firm has a fifty day simple moving average of $89.80 and a two-hundred day simple moving average of $97.72. The Cooper Companies, Inc. has a twelve month low of $77.05 and a twelve month high of $112.38. The company has a market capitalization of $16.74 billion, a PE ratio of 42.92, a P/E/G ratio of 2.25 and a beta of 1.02. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $964.70 million during the quarter, compared to analysts’ expectations of $981.25 million. Research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Ratings Changes

COO has been the topic of several recent analyst reports. JPMorgan Chase & Co. lowered their price target on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Friday, March 7th. Morgan Stanley dropped their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. Robert W. Baird decreased their price target on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a report on Friday, March 7th. BNP Paribas raised shares of Cooper Companies to a “hold” rating in a report on Thursday, March 13th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $115.00 target price (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.